What is Lucira Health Probability of Financial Distress (%)?
Probability of Financial Distress (%) measures the probability that a company will go bankrupt in the upcoming year given its current financial position. A higher ratio indicates a larger probability of bankruptcy for the company, while a lower ratio indicates a healthier fundamental. As of today, Lucira Health's Probability of Financial Distress (%) is 0.00%.
Like the Altman Z-Score, the PFD measures a company's bankruptcy risk. However, the main drawback of the Z-score is it does not apply to banks and insurance companies. According to Investopedia, the concept of "working capital" does not apply to banks and insurance companies, as financial institutions do not have typical current assets or current liabilities like inventories or accounts payable.
Competitive Comparison of Lucira Health's Probability of Financial Distress (%)
For the Medical Devices subindustry, Lucira Health's Probability of Financial Distress (%), along with its competitors' market caps and Probability of Financial Distress (%) data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lucira Health's Probability of Financial Distress (%) Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Lucira Health's Probability of Financial Distress (%) distribution charts can be found below:
* The bar in red indicates where Lucira Health's Probability of Financial Distress (%) falls into.
Lucira Health Probability of Financial Distress (%) Calculation
Probability of Financial Distress (%) (PFD) was developed by John Campbell, Jens Hilscher and Jan Szilagyi in their Search of Distress Risk. It measures the probability that a company will go bankrupt within the next 12 months given its current financial position.
The Probability of Financial Distress (%) was obtained by a logit probability model based on eight explanatory variables. The logit formula to compute the probability of financial distress (LPFD) is given below:
| LPFD | = | -20.12 * NIMTAAVG | + | 1.60 * TLMTA | - | 7.88 * EXRETAVG | + | 1.55 * SIGMA | - | 0.005 * RSIZE | - | 2.27 * CASHMTA | + | 0.070 * MB | - | 0.09 * PRICE | - | 8.87 |
| = | 0.00 |
The Probability of Financial Distress (%) (PFD) was then obtianed by:
| PFD | = | 1 | / | (1 + e^(-LPFD)) | * | 100% |
| = | 0.00% |
The eight explanatory variables are:
1. NIMTAAVG = Net Income to Market Total Assets
*Note that for companies reported quarterly, geometrically declining weighted quarterly Net Income data in latest four quarters are used.
2. TLMTA = Total liabilities to Market Total Assets
3. CASHMTA = Cash to Market Total Assets
For non-financial companies, CASHMTA is measured as:
4. EXRETAVG = Excess Return compared to the S&P 500
EXRETAVG is the weighted excess return compared to the S&P 500 in past 12 month. Geometrically declining weights are imposed on the monthly excess return to reflect lagged information. The weight is halved each quarter.
5. SIGMA = Standard Deviation of Daily Returns
For sigma, we use the annualized standard deviation of a company's returns over the past 92 days (or 63 trading days).
6. RSIZE = Relative Size
| RSIZE | = | log (Market Cap | / | Total Market Cap of S&P 500 companies) |
7. MB = Market to Adjusted Book Equity Ratio
8. PRICE
PRICE is measured as the log of the stock price, capped at log(15).
Lucira Health (Lucira Health) Business Description
Traded in Other Exchanges
N/A
Address
1412 62nd Street, Emeryville, CA, USA, 94608
Lucira Health Inc is a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits. It has developed a testing platform that produces high-complexity-laboratory-accurate molecular testing in a single-use and user-friendly test kit that is powered by two AA batteries and fit in the palm of a hand. The company's initial focus is within respiratory diseases, and initially for COVID-19 and influenza Types A and B indications.
Executives
| Anthony Joseph Allen |
officer: Chief Operations Officer |
1412 62ND STREET, EMERYVILLE CA 94608 |
| Epq Llc, Lcovd Safe Ps |
other: Less than 10% owner |
9650 GATEWAY DRIVE, SUITE 200, RENO NV 89521 |
| Chad Boeding |
other: CEO of 10% owner |
ONE LOMBARD STREET, SUITE 200, SAN FRANCISCO CA 94111 |
| Epiq Capital Group, Llc |
10 percent owner |
ONE LOMBARD STREET, SUITE 200, SAN FRANCISCO CA 94111 |
| Epq Llc, Lcovd Ps |
10 percent owner |
9650 GATEWAY DRIVE, SUITE 200, RENO NV 89521 |
| Epq Llc, Lflu Ps |
other: Less than 10% owner |
9650 GATEWAY DRIVE, SUITE 200, RENO NV 89521 |
| Epq Llc, Ltest Ps |
other: Less than 10% Owner |
9650 GATEWAY DRIVE, SUITE 200, RENO NV 89521 |
| Richard Clavano Narido |
officer: Interim CFO |
12 HANSEN CT, MORAGA CA 94556 |
| Ghazi Kashmolah |
officer: Ex. VP &Chief Quality Officer |
1412 62ND STREET, EMERYVILLE CA 94608 |
| Kevin Walter Collins |
officer: Chief Revenue Officer |
C/O LUCIRA HEALTH, INC., 1412 62ND STREET, EMERYVILLE CA 94608 |
| Dan George |
officer: CFO and Treasurer |
1412 62ND STREET, EMERYVILLE CA 94608 |
| Erik T. Engelson |
director, officer: President and Chief Executive |
1412 62ND STREET, EMERYVILLE CA 94608 |
| Debkishore Mitra |
director, officer: Chief Technology Officer |
1412 62ND STREET, EMERYVILLE CA 94608 |
| Tamanna Prashar |
officer: Vice President |
1412 62ND STREET, EMERYVILLE CA 94608 |
| Alison Mccauley |
director |
C/O LUCIRA HEALTH, INC., 1412 62ND STREET, EMERYVILLE CA 94608 |
Lucira Health (Lucira Health) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LHDXQ has been successfully added to your